Purchase Order 36C77026P0086
Award Date 8/14/26
Potential Completion Date 8/28/30
Potential Value $1.3M
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Schaumburg, IL, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
6
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Health and Human Services, through the Office of the Assistant Secretary for Preparedness and Response, awarded a $16,638,758.40 firm fixed-price delivery order contract to Sagent Pharmaceuticals, Inc. for the supply of Ciprofloxacin Solution for Injection, 400mg/200ml Flexi-Bag. The contract has an ultimate completion date of September 30, 2026 and is not set aside for any specific business designation. Sagent Pharmaceuticals, a for-profit pharmaceutical manufacturer...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Sagent Pharmaceuticals, Inc., a specialty pharmaceutical manufacturer and prime federal contractor. The $1,930,003.20 firm fixed-price contract is for the delivery of Ciprofloxacin HCL 400mg/200ml, an injectable antibiotic, to support military healthcare programs and other federal medical needs. The contract is not set aside and is issued under Sagent Pharmaceuticals' existing $29.6 million...
- Sagent Pharmaceuticals, Inc. has been awarded an $81 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical indefinite-delivery/indefinite-quantity contract to supply 400mg/200ml ciprofloxacin hydrochloride in 5% dextrose intravenous solution. Performance will occur in Hoffman Estates, Illinois by June 7, 2023. The delivery order was awarded on June 2, 2023 without a set-aside designation to fulfill the agency's requirements for this antibiotic intravenous...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Sagent Pharmaceuticals, Inc., a specialty pharmaceutical manufacturer, for the supply of ciprofloxacin hydrochloride 400mg/200ml in 5% dextrose solution. The order, valued at $1,313,107.20, was issued under an existing indefinite delivery/indefinite quantity (ID/IQ) contract between Sagent Pharmaceuticals and the DLA, with a period of performance through March 3, 2031. Sagent Pharmaceuticals is a...
- Sagent Pharmaceuticals, Inc. has been awarded an $81 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical blanket purchase agreement to supply 400mg/200ml bottles of ciprofloxacin hydrochloride 5% dex solution. Performance will occur in Hoffman Estates, Illinois by April 13, 2023. The Defense Logistics Agency Troop Support Medical supports the healthcare needs of military members, indicating the ciprofloxacin will be used to treat bacterial infections in...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Sagent Pharmaceuticals, Inc., a specialty pharmaceutical manufacturer. The contract is for the delivery of CIPROFLOXACIN HCL 400MG/200ML, IN 5% DEX, a critical antibiotic medication, with a ceiling value of $1,198,540.80 and a completion date of February 22, 2017. Sagent Pharmaceuticals is a prime federal contractor and has been awarded other significant federal contract...
- Sagent Pharmaceuticals, Inc. has been awarded an $81 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical blanket purchase agreement to supply 400mg/200ml ciprofloxacin hydrochloride in 5% dextrose intravenous solution. Performance will occur in Hoffman Estates, Illinois by June 7, 2023. The Defense Logistics Agency Troop Support Medical agency facilitates healthcare commodity management for the Department of Defense and this delivery order supports their...
- Sagent Pharmaceuticals, Inc. has been awarded a four hundred eighty-nine dollar delivery order contract from the Defense Logistics Agency Troop Support Medical to supply Ciprofloxacin HCl 400mg/200ml in 5% Dextrose. The contract has a firm fixed price and requires delivery by May 30, 2023. The place of performance will be Sagent's facility located in Hoffman Estates, Illinois. No set aside provisions were applied to this delivery order under the agency's existing pharmaceutical contracts. The...
- Sagent Pharmaceuticals, Inc. has been awarded an $81 firm fixed price delivery order against the Defense Logistics Agency Troop Support Medical blanket purchase agreement to supply 400mg/200ml bottles of ciprofloxacin hydrochloride 5% dex solution. Performance will occur in Hoffman Estates, Illinois by June 7, 2023. The Defense Logistics Agency Troop Support Medical procurement supports medical readiness for the U.S. armed forces by acquiring and delivering pharmaceuticals and other critical...
- This firm-fixed-price purchase order contract was awarded by the Department of Veterans Affairs (VA) to Pfizer Inc. for the pharmaceutical product CIPROFLOXACIN 400 MG/200ML-D5W. The contract has a ceiling value of $243,101.25 and a completion date of October 30, 2024. The contract was awarded on September 30, 2024, and was not set aside for any small business programs. Pfizer, a large pharmaceutical manufacturer, will provide the medication to support the VA's Consolidated Mail Outpatient...
The Department of Veterans Affairs Veterans Integrated Service Network 12 awarded a purchase order to Sagent Pharmaceuticals, Inc., for ciprofloxacin intravenous piggyback (IVPB) on August 14, 2026, with a ceiling value of $1,337,900.00. The order carries no set-aside designation. Place of performance is Schaumburg, Illinois. The contract is firm fixed price and runs through August 28, 2030. The pre-solicitation notice (36C77026Q0112) posted April 14, 2026, was designated Total Small Business set-aside and specified an estimated quantity of 765 units of ciprofloxacin 400 milligram/200 milliliter in dextrose 5% solution across the performance period.
Generated 8/12/26, 10:13 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $275.6k | 8/10/26 |